Cargando…

Cancer metabolism and intervention therapy

Metabolic reprogramming with heterogeneity is a hallmark of cancer and is at the basis of malignant behaviors. It supports the proliferation and metastasis of tumor cells according to the low nutrition and hypoxic microenvironment. Tumor cells frantically grab energy sources (such as glucose, fatty...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Huakan, Li, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607959/
https://www.ncbi.nlm.nih.gov/pubmed/35006438
http://dx.doi.org/10.1186/s43556-020-00012-1
_version_ 1784602664759197696
author Zhao, Huakan
Li, Yongsheng
author_facet Zhao, Huakan
Li, Yongsheng
author_sort Zhao, Huakan
collection PubMed
description Metabolic reprogramming with heterogeneity is a hallmark of cancer and is at the basis of malignant behaviors. It supports the proliferation and metastasis of tumor cells according to the low nutrition and hypoxic microenvironment. Tumor cells frantically grab energy sources (such as glucose, fatty acids, and glutamine) from different pathways to produce a variety of biomass to meet their material needs via enhanced synthetic pathways, including aerobic glycolysis, glutaminolysis, fatty acid synthesis (FAS), and pentose phosphate pathway (PPP). To survive from stress conditions (e.g., metastasis, irradiation, or chemotherapy), tumor cells have to reprogram their metabolism from biomass production towards the generation of abundant adenosine triphosphate (ATP) and antioxidants. In addition, cancer cells remodel the microenvironment through metabolites, promoting an immunosuppressive microenvironment. Herein, we discuss how the metabolism is reprogrammed in cancer cells and how the tumor microenvironment is educated via the metabolic products. We also highlight potential metabolic targets for cancer therapies.
format Online
Article
Text
id pubmed-8607959
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-86079592021-12-01 Cancer metabolism and intervention therapy Zhao, Huakan Li, Yongsheng Mol Biomed Review Metabolic reprogramming with heterogeneity is a hallmark of cancer and is at the basis of malignant behaviors. It supports the proliferation and metastasis of tumor cells according to the low nutrition and hypoxic microenvironment. Tumor cells frantically grab energy sources (such as glucose, fatty acids, and glutamine) from different pathways to produce a variety of biomass to meet their material needs via enhanced synthetic pathways, including aerobic glycolysis, glutaminolysis, fatty acid synthesis (FAS), and pentose phosphate pathway (PPP). To survive from stress conditions (e.g., metastasis, irradiation, or chemotherapy), tumor cells have to reprogram their metabolism from biomass production towards the generation of abundant adenosine triphosphate (ATP) and antioxidants. In addition, cancer cells remodel the microenvironment through metabolites, promoting an immunosuppressive microenvironment. Herein, we discuss how the metabolism is reprogrammed in cancer cells and how the tumor microenvironment is educated via the metabolic products. We also highlight potential metabolic targets for cancer therapies. Springer Singapore 2021-02-20 /pmc/articles/PMC8607959/ /pubmed/35006438 http://dx.doi.org/10.1186/s43556-020-00012-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Zhao, Huakan
Li, Yongsheng
Cancer metabolism and intervention therapy
title Cancer metabolism and intervention therapy
title_full Cancer metabolism and intervention therapy
title_fullStr Cancer metabolism and intervention therapy
title_full_unstemmed Cancer metabolism and intervention therapy
title_short Cancer metabolism and intervention therapy
title_sort cancer metabolism and intervention therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607959/
https://www.ncbi.nlm.nih.gov/pubmed/35006438
http://dx.doi.org/10.1186/s43556-020-00012-1
work_keys_str_mv AT zhaohuakan cancermetabolismandinterventiontherapy
AT liyongsheng cancermetabolismandinterventiontherapy